
Validea's guru fundamental report indicates that LAM RESEARCH CORP (LRCX) receives a 100% rating based on their Patient Investor model, which is based on the published strategy of Warren Buffett. The strategy favors firms with predictable profitability, low debt, and reasonable valuations, all of which LRCX passes according to the model's criteria. The analysis suggests strong interest in the stock based on the firm’s underlying fundamentals and valuation.
Lam Research Corp (LRCX) has garnered a perfect 100% rating from Validea's Patient Investor model, which is structured on Warren Buffett's investment tenets emphasizing long-term, predictable profitability, low debt, and reasonable valuations. This top-tier score, significantly above the 90% threshold indicating strong interest, reflects LRCX's successful fulfillment of all criteria within this specific strategy, encompassing earnings predictability, debt service, return on equity, return on total capital, free cash flow, use of retained earnings, share repurchase, initial rate of return, and expected return. As a large-cap growth stock in the Semiconductors industry, this comprehensive endorsement based on underlying fundamentals and valuation, coupled with an 'extremely positive' sentiment score of 0.9 for LRCX, highlights a strong quantitative assessment of the company's financial health and investment appeal according to this particular model.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
extremely positive
Sentiment Score
0.90
Ticker Sentiment